Angelica acutiloba root attenuates insulin resistance induced by high-fructose diet in rats

Phytotherapy Research

Volumn 25, Issue 9, 2011, Pages 1283-1293

  Liu, I Min ^a   Tzeng, Thing Fong ^b   Liou, Shorong Shii ^a   Chang, Chia Ju ^c  

^a TAJEN UNIVERSITY   (Taiwan)

^b Pao Chien Hospital   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Angelica acutiloba root; fructose; insulin resistance; insulin sensitivity; oral glucose tolerance test

Indexed keywords

ANGELICA ACUTILOBA EXTRACT; FRUCTOSE; GLUCOSE TRANSPORTER 4; GLYCOGEN; GLYCOSYLATED HEMOGLOBIN; INSULIN; LIPOPROTEIN LIPASE; PHOSPHOENOLPYRUVATE CARBOXYLASE; PIOGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; LIPID; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHOENOLPYRUVATE CARBOXYKINASE 1 (SOLUBLE) PROTEIN, RAT; PLANT EXTRACT; SIGNAL PEPTIDE; SLC2A4 PROTEIN, RAT;

ANGELICA; ANGELICA ACUTILOBA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DRUG EFFECT; DYSLIPIDEMIA; ENZYME ACTIVITY; GLYCOGEN LIVER LEVEL; HEMOGLOBIN BLOOD LEVEL; HORMONE ACTION; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; PLANT ROOT; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; TREATMENT DURATION; ANIMAL; BODY WEIGHT; CHEMISTRY; DRUG EFFECTS; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; LIVER; METABOLISM; WISTAR RAT;

ANGELICA ACUTILOBA; ANGELICA SINENSIS; RATTUS;

ANGELICA; ANIMALS; BODY WEIGHT; FRUCTOSE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN; HOMEOSTASIS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPIDS; LIVER; MALE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PLANT EXTRACTS; PLANT ROOTS; RATS, WISTAR; THIAZOLIDINEDIONES;

EID: 80052279907     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3403     Document Type: Article

References (33)

1. Astrup A, Finer N,. 2001. Redefining type 2 diabetes: disability or obesity dependent diabetes mellitus. Obes Rev 1: 57-59.
2. Baños G, Pérez-Torres I, El Hafidi M,. 2008. Medicinal agents in the metabolic syndrome. Cardiovasc Hematol Agents Med Chem 6: 237-252.
3. Carvalho E, Rondinone C, Smith U,. 2000. Insulin resistance in fat cells from obese Zucker rats-evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4. Mol Cell Biochem 206: 7-16. (Pubitemid 30246501)
4. Consoli A, Nurjhan N, Capani F, Gerich J,. 1989. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38: 550-557. (Pubitemid 19125601)
5. Ding SY, Shen ZF, Chen YT, Sun SJ, Liu Q, Xie MZ,. 2005. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats. Acta Pharmacol Sin 26: 575-580. (Pubitemid 40676168)
6. Folch J, Lees M, Sloane-Stanley GH,. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-506.
7. Friedewald WT, Levy RI, Fredrickson DS,. 1972. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18: 499-502.
8. Goldberg IJ,. 1996. Lipoprotein lipase and lipolysis: Central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 37: 693-707. (Pubitemid 26140808)
9. Granberry MC, Hawkins JB, Franks AM,. 2007. Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure. Am J Health Syst Pharm 64: 931-936. (Pubitemid 46676694)
10. GRIN Taxonomy for Plants. 2010. United States Department of Agriculture Agricultural Research Service, Beltsville Area. Available on-line at.
11. Grundy SM,. 2007. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92: 399-404.
12. Hanson RW, Reshef L,. 1997. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem 66: 581-611. (Pubitemid 27274668)
13. Hodge HC, Downs WL, Panner BS, Smith DW, Maynard EA,. 1967. Oral toxicity and metabolism of diuron (N-(3,4-dichlorophenyl)-N',N'-dimethylurea) in rats and dogs. Food Cosmet Toxicol 5: 513-531.
14. Hu G, Rico-Sanz J, Lakka TA, Tuomilehto J,. 2006. Exercise, genetics and prevention of type 2 diabetes. Essays Biochem 42: 177-192.
15. Huntley AL, Ernst EA,. 2003. Systematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause 10: 465-476.
16. Hyakukoku M, Higashiura K, Ura N, et al,. 2003. Tissue-specific impairment of insulin signaling in vasculature and skeletal muscle of fructose-fed rats. Hypertens Res 26: 169-176. (Pubitemid 36372337)
17. Ishiki M, Klip A,. 2005. Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners. Endocrinology 146: 5071-5078. (Pubitemid 41653019)
18. Krishnamurti U, Steffes MW,. 2001. Glycohemoglobin: a primary predictor of the development or reversal of complications of diabetes mellitus. Clin Chem 47: 1157-1165. (Pubitemid 32579102)
19. Le KA, Tappy L,. 2006. Metabolic effects of fructose. Curr Opin Clin Nutr Metab Care 9: 469-475. (Pubitemid 44097820)
20. Li X, Hansen PA, Xi L, Chandraratna RA, Burant CF,. 2005. Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor gamma and retinoic acid X receptors. J Biol Chem 280: 38317-38327. (Pubitemid 43860306)
21. Lu GH, Chan K, Liang YZ, et al,. 2005. Development of high-performance liquid chromatographic fingerprints for distinguishing Chinese Angelica from related umbelliferae herbs. J Chromatogr A 1073: 383-392. (Pubitemid 40544514)
22. Matsuda M, DeFronzo RA,. 1999. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diab Care 22: 1462-1470. (Pubitemid 29418240)
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. (Pubitemid 15018832)
24. Mayes PA,. 1993. Intermediary metabolism of fructose. Am J Clin Nutr 58: 754S-765S. (Pubitemid 23319973)
25. McGuinness OP, Cherrington AD,. 2003. Effects of fructose on hepatic glucose metabolism. Curr Opin Clin Nutr Metab Care 6: 441-448. (Pubitemid 40684597)
26. Piao XL, Park JH, Cui J, Kim DH, Yoo HH,. 2007. Development of gas chromatographic/mass spectrometry-pattern recognition method for the quality control of Korean Angelica. J Pharm Biomed Anal 44: 1163-1167. (Pubitemid 47239286)
27. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM,. 1993. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 92: 141-146. (Pubitemid 23208989)
28. Rodriguez E, Pulido N, Romero R, Arrieta F, Panadero A, Rovira A,. 2004. Phosphatidylinositol 3-kinase activation is required for sulfonylurea stimulation of glucose transport in rat skeletal muscle. Endocrinology 145: 679-685. (Pubitemid 38183810)
29. Song XM, Ryder JW, Kawano Y, Chibalin AV, Krook A, Zierath JR,. 1999. Muscle fiber type specificity in insulin signal transduction. Am J Physiol 277: R1690-R1696. (Pubitemid 30043776)
30. Stanhope KL, Havel PJ,. 2008. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol 19: 16-24.
31. Van der Vies J,. 1954. Two methods for the determination of glycogen in liver. Biochem J 57: 410-416.
32. Wang YX,. 2010. PPARs: diverse regulators in energy metabolism and metabolic diseases. Cell Res 20: 124-137.
33. Zhao KJ, Dong TT, Tu PF, Song ZH, Lo CK, Tsim KW,. 2003. Molecular genetic and chemical assessment of radix Angelica (Danggui) in China. J Agric Food Chem 51: 2576-2583.